United States · FDA National Drug Code directory
Donepezil Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-030_4bf742a3-3c8f-4bd3-b973-54370cbef345
- Product NDC
- 33342-030
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Donepezil Hydrochloride
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20121214
- Source listing expiry
- 20261231
Source-listed ingredients
- DONEPEZIL HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (33342-030-06) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 33342-030-06
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (33342-030-07) · 33342-030-07
- 10 BLISTER PACK in 1 CARTON (33342-030-12) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 33342-030-12
- 4 BLISTER PACK in 1 CARTON (33342-030-60) / 7 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 33342-030-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →